1632 PREVALENCE OF TREATMENT FOR LOWER URINARY TRACT SYMPTOMS IN COMMUNITY DWELLING OLDER MEN

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Epidemiology and Natural History/Evaluation and Markers1 Apr 20101632 PREVALENCE OF TREATMENT FOR LOWER URINARY TRACT SYMPTOMS IN COMMUNITY DWELLING OLDER MEN J. Kellogg Parsons, Timothy J. Wilt, Patty Y. Wang, Elizabeth Barrett-Connor, Douglas C. Bauer, and Lynn M. Marshall J. Kellogg ParsonsJ. Kellogg Parsons La Jolla, CA More articles by this author , Timothy J. WiltTimothy J. Wilt Minneapolis, MN More articles by this author , Patty Y. WangPatty Y. Wang Portland, OR More articles by this author , Elizabeth Barrett-ConnorElizabeth Barrett-Connor La Jolla, CA More articles by this author , Douglas C. BauerDouglas C. Bauer San Francisco, CA More articles by this author , and Lynn M. MarshallLynn M. Marshall Portland, OR More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1413AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Lower urinary tract symptoms (LUTS) are highly prevalent among healthy older men living in the community. However, the prevalence of treatment for LUTS in community dwelling older men remains undefined. METHODS We evaluated 5,697 participants in MrOS, a prospective cohort study of community dwelling men aged 65 years and older. We characterized LUTS utilizing the American Urological Symptom Index (AUA-SI) at two time points: study entry and 2-year follow-up. We examined the prevalence of surgical or pharmacological treatment for benign prostatic hyperplasia (BPH) or LUTS after 2 years utilizing descriptive statistics. We classified LUTS as mild (AUA-SI ≤7) or moderate to severe (AUA-SI ≥8) and defined a clinically significant improvement in LUTS as a decrease of ≥ 4 points after 2 years. RESULTS At baseline, 3728 (65%) reported no history of prior treatment for LUTS or BPH. Of these men, 2201 (59%) reported mild and 1527 (41%) moderate to severe LUTS. After 2 years, among those with mild LUTS at baseline, 94% remained untreated, 2% reported BPH surgery, and 4% medication use. Among those with moderate to severe LUTS at baseline, 78% reported unchanged or substantially worsened (increase of ≥ 4 points) LUTS and 83% remained untreated, 4% reported surgery, and 12% medication use. Among men with baseline moderate or severe LUTS who had subsequent treatment, 29% reported clinically significant symptom improvement compared to 25% of untreated men (p= 0.40). In those who reported BPH/LUTS treatments, symptom improvement was more likely with surgery (39%) compared to medical therapy (26%) (p=0.05). CONCLUSIONS Despite a high prevalence of persistent and clinically significant LUTS, the prevalence of treatment with surgery or medication was low. Men who did not receive treatment were just as likely to report symptom improvement as those who did. These data suggest that therapies for LUTS are applied infrequently in healthy older men living in the community. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e631 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information J. Kellogg Parsons La Jolla, CA More articles by this author Timothy J. Wilt Minneapolis, MN More articles by this author Patty Y. Wang Portland, OR More articles by this author Elizabeth Barrett-Connor La Jolla, CA More articles by this author Douglas C. Bauer San Francisco, CA More articles by this author Lynn M. Marshall Portland, OR More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...